Literature DB >> 35650461

Myeloid-Derived Suppressor Cells May Predict the Occurrence of Postoperative Complications in Colorectal Cancer Patients-a Pilot Study.

Joanna Rogala1, Izabela Siemińska2, Jarek Baran2, Mateusz Rubinkiewicz3, Justyna Zybaczyńska4, Antoni M Szczepanik1, Radoslaw Pach5.   

Abstract

Entities:  

Keywords:  Clavien-Dindo; Colorectal cancer; Early MDSC; Monocytic MDSC; Myeloid-derived suppressor cells; Polymorphonuclear MDSC; Postoperative complications

Year:  2022        PMID： 35650461     DOI： 10.1007/s11605-022-05364-3

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  5 in total

1.  Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy.

Authors:  C Marcela Diaz-Montero; Mohamed Labib Salem; Michael I Nishimura; Elizabeth Garrett-Mayer; David J Cole; Alberto J Montero
Journal:  Cancer Immunol Immunother       Date:  2008-04-30       Impact factor: 6.968

Review 2.  Myeloid-derived suppressor cells coming of age.

Authors:  Filippo Veglia; Michela Perego; Dmitry Gabrilovich
Journal:  Nat Immunol       Date:  2018-01-18       Impact factor: 25.606

3.  Myeloid-derived suppressor cell function and epigenetic expression evolves over time after surgical sepsis.

Authors:  McKenzie K Hollen; Julie A Stortz; Dijoia Darden; Marvin L Dirain; Dina C Nacionales; Russell B Hawkins; Michael C Cox; Maria-Cecilia Lopez; Jaimar C Rincon; Ricardo Ungaro; Zhongkai Wang; Quran Wu; Babette Brumback; Marie-Pierre L Gauthier; Michael Kladde; Christiaan Leeuwenburgh; Mark Segal; Azra Bihorac; Scott Brakenridge; Frederick A Moore; Henry V Baker; Alicia M Mohr; Lyle L Moldawer; Philip A Efron
Journal:  Crit Care       Date:  2019-11-13       Impact factor: 9.097

4.  Mo-MDSCs are pivotal players in colorectal cancer and may be associated with tumor recurrence after surgery.

Authors:  Izabela Siemińska; Kazimierz Węglarczyk; Marta Walczak; Agata Czerwińska; Radosław Pach; Mateusz Rubinkiewicz; Antoni Szczepanik; Maciej Siedlar; Jarek Baran
Journal:  Transl Oncol       Date:  2022-01-21       Impact factor: 4.243
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.